世界の筋緊張性ジストロフィー薬市場2019

• 英文タイトル：Global Myotonic Dystrophy Drug Sales Market Report 2019

• レポートコード：QYR9N2788
• 出版社/出版日：QYResearch / 2019年6月10日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、101ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥592,000 (USD4,000)	▷ お問い合わせ
Enterprise License	￥1,184,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査レポートでは、筋緊張性ジストロフィー薬の世界市場について調査・分析し、筋緊張性ジストロフィー薬のメーカー別販売量、市場シェア分析、種類別販売分析（ISIS-DMPKRx
、PRO-135
、SRT-152
、VAL-0411
、その他）、用途別販売分析（病院、診療所、ホーム用、その他）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、インド）、価格動向、企業動向、市場規模予測などを含め、以下の構成でお届けいたします。

・筋緊張性ジストロフィー薬市場概要
・筋緊張性ジストロフィー薬のメーカー別販売量・メーカー別シェア
・筋緊張性ジストロフィー薬の種類別販売量（ISIS-DMPKRx
、PRO-135
、SRT-152
、VAL-0411
、その他）
・筋緊張性ジストロフィー薬の用途別販売量（病院、診療所、ホーム用、その他）
・筋緊張性ジストロフィー薬の地域別販売量・市場シェア
・筋緊張性ジストロフィー薬の米国市場規模（2014年-2019年）
・筋緊張性ジストロフィー薬のヨーロッパ市場規模（2014年-2019年）
・筋緊張性ジストロフィー薬の中国市場規模（2014年-2019年）
・筋緊張性ジストロフィー薬の日本市場規模（2014年-2019年）
・筋緊張性ジストロフィー薬の東南アジア市場規模（2014年-2019年）
・筋緊張性ジストロフィー薬のインド市場規模（2014年-2019年）
・筋緊張性ジストロフィー薬メーカー分析（企業概要、製品概要、販売量、売上、価格等）
・筋緊張性ジストロフィー薬のコスト分析
・筋緊張性ジストロフィー薬販売チャネル、流通業者、顧客
・筋緊張性ジストロフィー薬の世界市場動向・機会・成長要因・課題
・筋緊張性ジストロフィー薬の種類別世界市場予測（ISIS-DMPKRx
、PRO-135
、SRT-152
、VAL-0411
、その他）
・筋緊張性ジストロフィー薬の用途別世界市場予測（病院、診療所、ホーム用、その他）
・筋緊張性ジストロフィー薬の米国市場予測（2019年-2025年）
・筋緊張性ジストロフィー薬のヨーロッパ市場予測（2019年-2025年）
・筋緊張性ジストロフィー薬の中国市場予測（2019年-2025年）
・筋緊張性ジストロフィー薬の日本市場予測（2019年-2025年）
・筋緊張性ジストロフィー薬の東南アジア市場予測（2019年-2025年）
・筋緊張性ジストロフィー薬のインド市場予測（2019年-2025年）
...

The global Myotonic Dystrophy Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report studies the global Myotonic Dystrophy Drug market status and forecast, categorizes the global Myotonic Dystrophy Drug market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Major manufacturers covered in this report
BioMarin Pharmaceutical Inc.
F. Hoffmann-La Roche Ltd.
Genzyme Corporation
Isis Pharmaceuticals, Inc.
Marina Biotech, Inc.
Valentia Biopharma S.L.
…

In view of regional level, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Segment by Type
ISIS-DMPKRx
PRO-135
SRT-152
VAL-0411
Others

Segment by Application
Hospital
Clinic
Home Use
Others

レポート目次

Table of Contents

Global Myotonic Dystrophy Drug Sales Market Report 2019
1 Myotonic Dystrophy Drug Market Overview
1.1 Myotonic Dystrophy DrugProduct Overview
1.2 Myotonic Dystrophy Drug Segment by Type
1.2.1 Global Myotonic Dystrophy Drug Sales Comparison by Types (2014-2025)
1.2.2 ISIS-DMPKRx
1.2.3 PRO-135
1.2.4 SRT-152
1.2.5 VAL-0411
1.2.6 Others
1.3 Myotonic Dystrophy Drug Segment by Application
1.3.1 Global Myotonic Dystrophy Drug Sales Comparison by Application (2014-2025)
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Home Use
1.3.4 Others
1.4 Myotonic Dystrophy Drug Market by Region
1.4.1 Global Myotonic Dystrophy Drug Revenue Comparison by Region (2014-2025)
1.4.2 United States Myotonic Dystrophy Drug Status and Prospect (2014-2025)
1.4.3 Europe Myotonic Dystrophy Drug Status and Prospect (2014-2025)
1.4.4 China Myotonic Dystrophy Drug Status and Prospect (2014-2025)
1.4.5 Japan Myotonic Dystrophy Drug Status and Prospect (2014-2025)
1.4.6 Southeast Asia Myotonic Dystrophy Drug Status and Prospect (2014-2025)
1.4.7 India Myotonic Dystrophy Drug Status and Prospect (2014-2025)
1.5 Global Myotonic Dystrophy Drug Sales and Revenue (2014-2025)
1.5.1 Global Myotonic Dystrophy Drug Sales and Growth Rate (2014-2025)
1.5.2 Global Myotonic Dystrophy Drug Revenue and Growth Rate (2014-2025)

2 Myotonic Dystrophy Drug by Company, Region, Type and Application
2.1 Global Myotonic Dystrophy Drug Market Competition by Companies
2.1.1 Global Myotonic Dystrophy Drug Sales Market Share of Key Companies (2014-2019)
2.1.2 Global Myotonic Dystrophy Drug Revenue Market Share by Company (2014-2019)
2.2 Global Myotonic Dystrophy Drug Sales and Revenue by Region
2.2.1 Global Myotonic Dystrophy Drug Sales Market Share by Region (2014-2019)
2.2.2 Global Myotonic Dystrophy Drug Revenue Market Share by Region (2014-2019)
2.3 Global Myotonic Dystrophy Drug Sales and Revenue by Type
2.3.1 Global Myotonic Dystrophy Drug Sales Market Share by Type (2014-2019)
2.3.2 Global Myotonic Dystrophy Drug Revenue Market Share by Type (2014-2019)
2.4 Global Myotonic Dystrophy Drug Sales by Application

3 United States Myotonic Dystrophy Drug Sales, Revenue and Price
3.1 United States Myotonic Dystrophy Drug Sales and Revenue (2014-2019)
3.1.1 United States Myotonic Dystrophy Drug Sales Growth Rate (2014-2019)
3.1.2 United States Myotonic Dystrophy Drug Revenue Growth Rate (2014-2019)
3.1.3 United States Myotonic Dystrophy Drug Price Trend (2014-2019)
3.2 United States Myotonic Dystrophy Drug Sales Market Share by Company
3.3 United States Myotonic Dystrophy Drug Sales Market Share by Type
3.4 United States Myotonic Dystrophy Drug Sales Market Share by Application

4 Europe Myotonic Dystrophy Drug Sales, Revenue and Price
4.1 Europe Myotonic Dystrophy Drug Sales and Value (2014-2019)
4.1.1 Europe Myotonic Dystrophy Drug Sales Growth Rate (2014-2019)
4.1.2 Europe Myotonic Dystrophy Drug Revenue Growth Rate (2014-2019)
4.1.3 Europe Myotonic Dystrophy Drug Price Trend (2014-2019)
4.2 Europe Myotonic Dystrophy Drug Sales Market Share by Company
4.3 Europe Myotonic Dystrophy Drug Sales Market Share by Type
4.4 Europe Myotonic Dystrophy Drug Sales Market Share by Application

5 China Myotonic Dystrophy Drug Sales, Revenue and Price
5.1 China Myotonic Dystrophy Drug Sales and Revenue (2014-2019)
5.1.1 China Myotonic Dystrophy Drug Sales Growth Rate (2014-2019)
5.1.2 China Myotonic Dystrophy Drug Revenue Growth Rate (2014-2019)
5.1.3 China Myotonic Dystrophy Drug Price Trend (2014-2019)
5.2 China Myotonic Dystrophy Drug Sales Market Share by Company
5.3 China Myotonic Dystrophy Drug Sales Market Share by Type
5.4 China Myotonic Dystrophy Drug Sales Market Share by Application

6 Japan Myotonic Dystrophy Drug Sales, Revenue and Price
6.1 Japan Myotonic Dystrophy Drug Sales and Value (2014-2019)
6.1.1 Japan Myotonic Dystrophy Drug Sales Growth Rate (2014-2019)
6.1.2 Japan Myotonic Dystrophy Drug Revenue Growth Rate (2014-2019)
6.1.3 Japan Myotonic Dystrophy Drug Price Trend (2014-2019)
6.2 Japan Myotonic Dystrophy Drug Sales Market Share by Company
6.3 Japan Myotonic Dystrophy Drug Sales Market Share by Type
6.4 Japan Myotonic Dystrophy Drug Sales Market Share by Application

7 Southeast Asia Myotonic Dystrophy Drug Sales, Revenue and Price
7.1 Southeast Asia Myotonic Dystrophy Drug Sales and Value (2014-2019)
7.1.1 Southeast Asia Myotonic Dystrophy Drug Sales Growth Rate (2014-2019)
7.1.2 Southeast Asia Myotonic Dystrophy Drug Revenue Growth Rate (2014-2019)
7.1.3 Southeast Asia Myotonic Dystrophy Drug Price Trend (2014-2019)
7.2 Southeast Asia Myotonic Dystrophy Drug Sales Market Share by Company
7.3 Southeast Asia Myotonic Dystrophy Drug Sales Market Share by Type
7.4 Southeast Asia Myotonic Dystrophy Drug Sales Market Share by Application

8 India Myotonic Dystrophy Drug Sales, Revenue and Price
8.1 India Myotonic Dystrophy Drug Sales and Value (2014-2019)
8.1.1 India Myotonic Dystrophy Drug Sales Growth Rate (2014-2019)
8.1.2 India Myotonic Dystrophy Drug Revenue Growth Rate (2014-2019)
8.1.3 India Myotonic Dystrophy Drug Price Trend (2014-2019)
8.2 India Myotonic Dystrophy Drug Sales Market Share by Company
8.3 India Myotonic Dystrophy Drug Sales Market Share by Type
8.4 India Myotonic Dystrophy Drug Sales Market Share by Application

9 Company Profiles and Key Figures in Myotonic Dystrophy Drug Business
9.1 BioMarin Pharmaceutical Inc.
9.1.1 BioMarin Pharmaceutical Inc. Myotonic Dystrophy Drug Production Sites and Area Served
9.1.2 Myotonic Dystrophy Drug Specification and Application
9.1.3 BioMarin Pharmaceutical Inc. Myotonic Dystrophy Drug Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Main Business and Markets Served
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 F. Hoffmann-La Roche Ltd. Myotonic Dystrophy Drug Production Sites and Area Served
9.2.2 Myotonic Dystrophy Drug Specification and Application
9.2.3 F. Hoffmann-La Roche Ltd. Myotonic Dystrophy Drug Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Main Business and Markets Served
9.3 Genzyme Corporation
9.3.1 Genzyme Corporation Myotonic Dystrophy Drug Production Sites and Area Served
9.3.2 Myotonic Dystrophy Drug Specification and Application
9.3.3 Genzyme Corporation Myotonic Dystrophy Drug Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Main Business and Markets Served
9.4 Isis Pharmaceuticals, Inc.
9.4.1 Isis Pharmaceuticals, Inc. Myotonic Dystrophy Drug Production Sites and Area Served
9.4.2 Myotonic Dystrophy Drug Specification and Application
9.4.3 Isis Pharmaceuticals, Inc. Myotonic Dystrophy Drug Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Main Business and Markets Served
9.5 Marina Biotech, Inc.
9.5.1 Marina Biotech, Inc. Myotonic Dystrophy Drug Production Sites and Area Served
9.5.2 Myotonic Dystrophy Drug Specification and Application
9.5.3 Marina Biotech, Inc. Myotonic Dystrophy Drug Sales, Revenue, Price and Gross Margin (2014-2019)
9.5.4 Main Business and Markets Served
9.6 Valentia Biopharma S.L.
9.6.1 Valentia Biopharma S.L. Myotonic Dystrophy Drug Production Sites and Area Served
9.6.2 Myotonic Dystrophy Drug Specification and Application
9.6.3 Valentia Biopharma S.L. Myotonic Dystrophy Drug Sales, Revenue, Price and Gross Margin (2014-2019)
9.6.4 Main Business and Markets Served
…

10 Myotonic Dystrophy Drug Maufacturing Cost Analysis
10.1 Myotonic Dystrophy Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Key Raw Materials Price Trend
10.1.3 Key Suppliers of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.3 Manufacturing Process Analysis of Myotonic Dystrophy Drug
10.4 Myotonic Dystrophy Drug Industrial Chain Analysis

11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.2 Myotonic Dystrophy Drug Distributors List
11.3 Myotonic Dystrophy Drug Customers

12 Market Dynamics
12.1 Market Trends
12.2 Opportunities
12.3 Market Drivers
12.4 Challenges
12.5 Influence Factors

13 Myotonic Dystrophy Drug Market Forecast
13.1 Global Myotonic Dystrophy Drug Sales, Revenue and Price Forecast
13.1.1 Global Myotonic Dystrophy Drug Sales Growth Forecast (2019-2025)
13.1.2 Global Myotonic Dystrophy Drug Revenue Growth Forecast (2019-2025)
13.1.3 Global Myotonic Dystrophy Drug Price Trend Forecast (2019-2025)
13.2 Global Myotonic Dystrophy Drug Forecast by Region
13.2.1 Global Myotonic Dystrophy Drug Sales Growth Forecast by Region (2019-2025)
13.2.2 Global Myotonic Dystrophy Drug Revenue Growth Forecast by Region (2019-2025)
13.2.3 United States Myotonic Dystrophy Drug Sales, Revenue Growth Forecast (2019-2025)
13.2.4 Europe Myotonic Dystrophy Drug Sales, Revenue Growth Forecast (2019-2025)
13.2.5 China Myotonic Dystrophy Drug Sales, Revenue Growth Forecast (2019-2025)
13.2.6 Japan Myotonic Dystrophy Drug Sales, Revenue Growth Forecast (2019-2025)
13.2.7 Southeast Asia Myotonic Dystrophy Drug Sales, Revenue Growth Forecast (2019-2025)
13.2.8 India Myotonic Dystrophy Drug Sales, Revenue Growth Forecast (2019-2025)
13.3 Global Myotonic Dystrophy Drug Forecast by Type
13.3.1 Global Myotonic Dystrophy Drug Sales Forecast by Type (2019-2025)
13.3.2 Global Myotonic Dystrophy Drug Revenue Forecast by Type (2019-2025)
13.3.3 Global Myotonic Dystrophy Drug Price Forecast by Type (2019-2025)
13.4 Global Myotonic Dystrophy Drug Forecast by Application

14 Research Findings and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer

List of Tables and Figures

Market Breakdown by Region: Myotonic Dystrophy Drug Sales (K Pcs) and Value (Revenue: Million US$)
Market Breakdown by Type: Myotonic Dystrophy Drug Sales (K Pcs) and Revenue (Million US$)
Market Breakdown by Application: Myotonic Dystrophy Drug Sales (Jan)
Figure Myotonic Dystrophy Drug Product Picture
Table Global Myotonic Dystrophy Drug Sales (K Pcs) Growth Rate by Types (2014-2025)
Figure Global Myotonic Dystrophy Drug Sales Market Share by Types in 2018
Figure ISIS-DMPKRx Product Picture
Figure PRO-135 Product Picture
Figure SRT-152 Product Picture
Figure VAL-0411 Product Picture
Figure Others Product Picture
Table Global Myotonic Dystrophy Drug Sales (K Pcs) Comparison by Application (2014-2025)
Figure Global Sales Market Share of Myotonic Dystrophy Drug by Application in 2018
Figure Hospital Examples
Figure Clinic Examples
Figure Home Use Examples
Figure Others Examples
Table Global Market Myotonic Dystrophy Drug Revenue (Million USD) Comparison by Region 2014-2025
Figure United States Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (2014-2025)
Figure Global Myotonic Dystrophy Drug Sales (K Pcs) Growth Rate (2014-2025)
Figure Global Myotonic Dystrophy Drug Revenue (Million USD) Growth Rate (2014-2025)
Table Global Myotonic Dystrophy Drug Sales (K Pcs) of Key Companies (2014-2019)
Figure Global Myotonic Dystrophy Drug Sales by Company in 2018
Table Global Myotonic Dystrophy Drug Sales Share by Company (2014-2019)
Figure Global Myotonic Dystrophy Drug Sales Share by Company in 2018
Table Global Myotonic Dystrophy Drug Revenue (Million USD) by Company (2014-2019)
Figure Global Myotonic Dystrophy Drug Revenue (Million USD) by Company in 2018
Table Global Myotonic Dystrophy Drug Revenue Share by Company (2014-2019)
Figure Global Myotonic Dystrophy Drug Revenue Share by Company in 2018
Table Global Myotonic Dystrophy Drug Sales (K Pcs) Market Share by Region (2014-2019)
Table Global Myotonic Dystrophy Drug Sales Share by Region (2014-2019)
Figure Global Myotonic Dystrophy Drug Sales Share by Region in 2018
Table Global Myotonic Dystrophy Drug Revenue (Million USD) Market Share by Region (2014-2019)
Table Global Myotonic Dystrophy Drug Revenue Share by Region (2014-2019)
Figure Global Myotonic Dystrophy Drug Revenue Market Share by Region In 2018
Table Global Myotonic Dystrophy Drug Sales (K Pcs) by Type (2014-2019)
Table Global Myotonic Dystrophy Drug Sales Share by Type (2014-2019)
Figure Global Myotonic Dystrophy Drug Sales Growth Rate by Type in 2018
Table Global Myotonic Dystrophy Drug Revenue (Million USD) Market Share by Type (2014-2019)
Table Global Myotonic Dystrophy Drug Revenue Share by Type (2014-2019)
Figure Global Myotonic Dystrophy Drug Revenue Growth Rate by Type in 2018
Table Global Myotonic Dystrophy Drug Sales Market Share by Application (2014-2019)
Table Global Myotonic Dystrophy Drug Sales Share by Application (2014-2019)
Figure Global Myotonic Dystrophy Drug Sales Market Share by Application in 2018
Figure United States Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate (2014-2019)
Figure United States Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (2014-2019)
Figure United States Myotonic Dystrophy Drug Price (USD/Pcs) Trend (2014-2019)
Table United States Myotonic Dystrophy Drug Sales (K Pcs) by Company (2014-2019)
Table United States Myotonic Dystrophy Drug Sales Market Share by Company (2014-2019)
Figure United States Myotonic Dystrophy Drug Sales Market Share by Company in 2018
Table United States Myotonic Dystrophy Drug Sales (K Pcs) by Type (2014-2019)
Table United States Myotonic Dystrophy Drug Sales Market Share by Type (2014-2019)
Figure United States Myotonic Dystrophy Drug Sales Market Share by Type in 2018
Table United States Myotonic Dystrophy Drug Sales (K Pcs) by Application (2014-2019)
Table United States Myotonic Dystrophy Drug Sales Market Share by Application (2014-2019)
Figure United States Myotonic Dystrophy Drug Sales Market Share by Application in 2018
Figure Europe Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate (2014-2019)
Figure Europe Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (2014-2019)
Figure Europe Myotonic Dystrophy Drug Price (USD/Pcs) Trend (2014-2019)
Table Europe Myotonic Dystrophy Drug Sales (K Pcs) by Company (2014-2019)
Table Europe Myotonic Dystrophy Drug Sales Market Share by Company (2014-2019)
Figure Europe Myotonic Dystrophy Drug Sales Market Share by Company in 2018
Table Europe Myotonic Dystrophy Drug Sales (K Pcs) by Type (2014-2019)
Table Europe Myotonic Dystrophy Drug Sales Market Share by Type (2014-2019)
Figure Europe Myotonic Dystrophy Drug Sales Market Share by Type in 2018
Table Europe Myotonic Dystrophy Drug Sales (K Pcs) by Application (2014-2019)
Table Europe Myotonic Dystrophy Drug Sales Market Share by Application (2014-2019)
Figure Europe Myotonic Dystrophy Drug Sales Market Share by Application in 2018
Figure China Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate (2014-2019)
Figure China Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (2014-2019)
Figure China Myotonic Dystrophy Drug Price (USD/Pcs) Trend (2014-2019)
Table China Myotonic Dystrophy Drug Sales (K Pcs) by Company (2014-2019)
Table China Myotonic Dystrophy Drug Sales Market Share by Company (2014-2019)
Figure China Myotonic Dystrophy Drug Sales Market Share by Company in 2018
Table China Myotonic Dystrophy Drug Sales (K Pcs) by Type (2014-2019)
Table China Myotonic Dystrophy Drug Sales Market Share by Type (2014-2019)
Figure China Myotonic Dystrophy Drug Sales Market Share by Type in 2018
Table China Myotonic Dystrophy Drug Sales (K Pcs) by Application (2014-2019)
Table China Myotonic Dystrophy Drug Sales Market Share by Application (2014-2019)
Figure China Myotonic Dystrophy Drug Sales Market Share by Application in 2018
Figure Japan Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate (2014-2019)
Figure Japan Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (2014-2019)
Figure Japan Myotonic Dystrophy Drug Price (USD/Pcs) Trend (2014-2019)
Table Japan Myotonic Dystrophy Drug Sales (K Pcs) by Company (2014-2019)
Table Japan Myotonic Dystrophy Drug Sales Market Share by Company (2014-2019)
Figure Japan Myotonic Dystrophy Drug Sales Market Share by Company in 2018
Table Japan Myotonic Dystrophy Drug Sales (K Pcs) by Type (2014-2019)
Table Japan Myotonic Dystrophy Drug Sales Market Share by Type (2014-2019)
Figure Japan Myotonic Dystrophy Drug Sales Market Share by Type in 2018
Table Japan Myotonic Dystrophy Drug Sales (K Pcs) by Application (2014-2019)
Table Japan Myotonic Dystrophy Drug Sales Market Share by Application (2014-2019)
Figure Japan Myotonic Dystrophy Drug Sales Market Share by Application in 2018
Figure Southeast Asia Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate (2014-2019)
Figure Southeast Asia Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (2014-2019)
Figure Southeast Asia Myotonic Dystrophy Drug Price (USD/Pcs) Trend (2014-2019)
Table Southeast Asia Myotonic Dystrophy Drug Sales (K Pcs) by Company (2014-2019)
Table Southeast Asia Myotonic Dystrophy Drug Sales Market Share by Company (2014-2019)
Figure Southeast Asia Myotonic Dystrophy Drug Sales Market Share by Company in 2018
Table Southeast Asia Myotonic Dystrophy Drug Sales (K Pcs) by Type (2014-2019)
Table Southeast Asia Myotonic Dystrophy Drug Sales Market Share by Type (2014-2019)
Figure Southeast Asia Myotonic Dystrophy Drug Sales Market Share by Type in 2018
Table Southeast Asia Myotonic Dystrophy Drug Sales (K Pcs) by Application (2014-2019)
Table Southeast Asia Myotonic Dystrophy Drug Sales Market Share by Application (2014-2019)
Figure Southeast Asia Myotonic Dystrophy Drug Sales Market Share by Application in 2018
Figure India Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate (2014-2019)
Figure India Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (2014-2019)
Figure India Myotonic Dystrophy Drug Price (USD/Pcs) Trend (2014-2019)
Table India Myotonic Dystrophy Drug Sales (K Pcs) by Company (2014-2019)
Table India Myotonic Dystrophy Drug Sales Market Share by Company (2014-2019)
Figure India Myotonic Dystrophy Drug Sales Market Share by Company in 2018
Table India Myotonic Dystrophy Drug Sales (K Pcs) by Type (2014-2019)
Table India Myotonic Dystrophy Drug Sales Market Share by Type (2014-2019)
Figure India Myotonic Dystrophy Drug Sales Market Share by Type in 2018
Table India Myotonic Dystrophy Drug Sales (K Pcs) by Application (2014-2019)
Table India Myotonic Dystrophy Drug Sales Market Share by Application (2014-2019)
Figure India Myotonic Dystrophy Drug Sales Market Share by Application in 2018
Table BioMarin Pharmaceutical Inc. Myotonic Dystrophy Drug Production Sites and Area Served
Table BioMarin Pharmaceutical Inc. Myotonic Dystrophy Drug Specification and Application
Table BioMarin Pharmaceutical Inc. Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure BioMarin Pharmaceutical Inc. Myotonic Dystrophy Drug Sales Growth Rate (2014-2019)
Figure BioMarin Pharmaceutical Inc. Myotonic Dystrophy Drug Revenue Share in International Market (2014-2019)
Figure BioMarin Pharmaceutical Inc. Myotonic Dystrophy Drug Main Business and Markets Served
Table F. Hoffmann-La Roche Ltd. Myotonic Dystrophy Drug Production Sites and Area Served
Table F. Hoffmann-La Roche Ltd. Myotonic Dystrophy Drug Specification and Application
Table F. Hoffmann-La Roche Ltd. Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure F. Hoffmann-La Roche Ltd. Myotonic Dystrophy Drug Sales Growth Rate (2014-2019)
Figure F. Hoffmann-La Roche Ltd. Myotonic Dystrophy Drug Revenue Share in International Market (2014-2019)
Figure F. Hoffmann-La Roche Ltd. Myotonic Dystrophy Drug Main Business and Markets Served
Table Genzyme Corporation Myotonic Dystrophy Drug Production Sites and Area Served
Table Genzyme Corporation Myotonic Dystrophy Drug Specification and Application
Table Genzyme Corporation Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Genzyme Corporation Myotonic Dystrophy Drug Sales Growth Rate (2014-2019)
Figure Genzyme Corporation Myotonic Dystrophy Drug Revenue Share in International Market (2014-2019)
Figure Genzyme Corporation Myotonic Dystrophy Drug Main Business and Markets Served
Table Isis Pharmaceuticals, Inc. Myotonic Dystrophy Drug Production Sites and Area Served
Table Isis Pharmaceuticals, Inc. Myotonic Dystrophy Drug Specification and Application
Table Isis Pharmaceuticals, Inc. Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Isis Pharmaceuticals, Inc. Myotonic Dystrophy Drug Sales Growth Rate (2014-2019)
Figure Isis Pharmaceuticals, Inc. Myotonic Dystrophy Drug Revenue Share in International Market (2014-2019)
Figure Isis Pharmaceuticals, Inc. Myotonic Dystrophy Drug Main Business and Markets Served
Table Marina Biotech, Inc. Myotonic Dystrophy Drug Production Sites and Area Served
Table Marina Biotech, Inc. Myotonic Dystrophy Drug Specification and Application
Table Marina Biotech, Inc. Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Marina Biotech, Inc. Myotonic Dystrophy Drug Sales Growth Rate (2014-2019)
Figure Marina Biotech, Inc. Myotonic Dystrophy Drug Revenue Share in International Market (2014-2019)
Figure Marina Biotech, Inc. Myotonic Dystrophy Drug Main Business and Markets Served
Table Valentia Biopharma S.L. Myotonic Dystrophy Drug Production Sites and Area Served
Table Valentia Biopharma S.L. Myotonic Dystrophy Drug Specification and Application
Table Valentia Biopharma S.L. Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Valentia Biopharma S.L. Myotonic Dystrophy Drug Sales Growth Rate (2014-2019)
Figure Valentia Biopharma S.L. Myotonic Dystrophy Drug Revenue Share in International Market (2014-2019)
Figure Valentia Biopharma S.L. Myotonic Dystrophy Drug Main Business and Markets Served
Table Production Base and Market Concentration Rate of Raw Material
Figure Key Raw Materials Price Trend
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Myotonic Dystrophy Drug
Figure Manufacturing Process Analysis of Myotonic Dystrophy Drug
Figure Myotonic Dystrophy Drug Industrial Chain Analysis
Table Myotonic Dystrophy Drug Distributors List
Table Myotonic Dystrophy Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Figure Global Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Global Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Global Myotonic Dystrophy Drug Price (USD/Pcs) and Trend Forecast (2019-2025)
Table Global Myotonic Dystrophy Drug Sales (K Pcs) Forecast by Regions (2019-2025)
Figure Global Myotonic Dystrophy Drug Sales Market Share Forecast by Regions (2019-2025)
Figure Global Myotonic Dystrophy Drug Sales Market Share Forecast by Regions in 2025
Table Global Myotonic Dystrophy Drug Revenue (Million USD) Forecast by Regions (2019-2025)
Figure Global Myotonic Dystrophy Drug Revenue Market Share Forecast by Regions (2019-2025)
Figure Global Myotonic Dystrophy Drug Revenue Market Share Forecast by Regions in 2025
Figure United States Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure United States Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Europe Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Europe Myotonic Dystrophy Drug Revenue and Growth Rate Forecast (2019-2025)
Figure China Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure China Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Japan Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Japan Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure India Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure India Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Myotonic Dystrophy Drug Sales (K Pcs) Forecast by Type (2019-2025)
Figure Global Myotonic Dystrophy Drug Sales Market Share Forecast by Type (2019-2025)
Table Global Myotonic Dystrophy Drug Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Myotonic Dystrophy Drug Revenue Market Share Forecast by Type (2019-2025)
Table Global Myotonic Dystrophy Drug Price (USD/Pcs) Forecast by Type (2019-2025)
Table Global Myotonic Dystrophy Drug Sales (K Pcs) Forecast by Application (2019-2025)
Figure Global Myotonic Dystrophy Drug Sales Market Share Forecast by Application (2019-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界の遺伝性疾患薬市場2019

Global Genetic Disorders Drug Sales Market Report 2019
QYR9N1279 2019年6月10日 105Pages
本調査レポートでは、遺伝性疾患薬の世界市場について調査・分析し、遺伝性疾患薬のメーカー別販売量、市場シェア分析、種類別販売分析（嚢胞性線維症（CF）、デュシェンヌ型筋ジストロフィー（DMD）、リソソーム蓄積症（LSD）、発作性夜間血色素尿症（PNH））、用途別販売分析（診療所、病院）、地域別販売分析...

世界のデュピュイトラン拘縮薬市場2019

Global Dupuytren Contracture Drug Sales Market Report 2019
QYR9N0592 2019年6月10日 107Pages
本調査レポートでは、デュピュイトラン拘縮薬の世界市場について調査・分析し、デュピュイトラン拘縮薬のメーカー別販売量、市場シェア分析、種類別販売分析（ブピバカインER、MWPC-003、その他）、用途別販売分析（診療所、病院、その他）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、インド）...

世界の鼻ポリープ症薬市場2019

Global Nasal Polyposis Drug Sales Market Report 2019
QYR9N2827 2019年6月13日 105Pages
本調査レポートでは、鼻ポリープ症薬の世界市場について調査・分析し、鼻ポリープ症薬のメーカー別販売量、市場シェア分析、種類別販売分析（AK-001、デュピルマブ、プロピオン酸フルチカゾン、イフェトロバンナトリウム、オマリズマブ、その他）、用途別販売分析（病院、診療所、その他）、地域別販売分析（米国、ヨ...

世界のレノックス – ガースト症候群薬市場2019

Global Lennox-Gastaut Syndrome Drug Sales Market Report 2019
QYR9N2226 2019年6月10日 103Pages
本調査レポートでは、レノックス - ガースト症候群薬の世界市場について調査・分析し、レノックス - ガースト症候群薬のメーカー別販売量、市場シェア分析、種類別販売分析（ペラムパネル、カンナビジオール、NRP-2945、フェンフルラミン塩酸塩、その他）、用途別販売分析（病院、診療所、家庭）、地域別販売...

世界の角膜移植片拒絶反応薬市場2019

Global Corneal Graft Rejection Drug Sales Market Report 2019
QYR9N0145 2019年6月10日 109Pages
本調査レポートでは、角膜移植片拒絶反応薬の世界市場について調査・分析し、角膜移植片拒絶反応薬のメーカー別販売量、市場シェア分析、種類別販売分析（OXB-202、GB-301、シンデセルM、VGX-100、その他）、用途別販売分析（病院、診療所、その他）、地域別販売分析（米国、ヨーロッパ、中国、日本、...

世界の深部静脈血栓症（DVT）薬市場2019

Global Deep Vein Thrombosis (DVT) Drug Sales Market Report 2019
QYR9N0260 2019年6月10日 106Pages
本調査レポートでは、深部静脈血栓症（DVT）薬の世界市場について調査・分析し、深部静脈血栓症（DVT）薬のメーカー別販売量、市場シェア分析、種類別販売分析（血液希釈剤、組織プラスミノーゲンアクチベーター、その他の薬）、用途別販売分析（病院、診療所、ドラッグストア）、地域別販売分析（米国、ヨーロッパ、...

世界の下痢薬市場2019

Global Diarrhea Drug Sales Market Report 2019
QYR9N0348 2019年6月10日 107Pages
本調査レポートでは、下痢薬の世界市場について調査・分析し、下痢薬のメーカー別販売量、市場シェア分析、種類別販売分析（成人、子供）、用途別販売分析（家族、病院）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、インド）、価格動向、企業動向、市場規模予測などを含め、以下の構成でお届けいたします...

世界の草花粉アレルギー薬市場2019

Global Grass Pollen Allergy Drug Sales Market Report 2019
QYR9N1373 2019年6月10日 109Pages
本調査レポートでは、草花粉アレルギー薬の世界市場について調査・分析し、草花粉アレルギー薬のメーカー別販売量、市場シェア分析、種類別販売分析（BM-32、Pollinex Quattro Grass、その他）、用途別販売分析（ホーム用、病院、リサーチセンター）、地域別販売分析（米国、ヨーロッパ、中国、...

世界の多年生アレルギー性鼻炎薬市場2019

Global Perennial Allergic Rhinitis Drug Sales Market Report 2019
QYR9N3317 2019年6月13日 103Pages
本調査レポートでは、多年生アレルギー性鼻炎薬の世界市場について調査・分析し、多年生アレルギー性鼻炎薬のメーカー別販売量、市場シェア分析、種類別販売分析（APC-3000、Asapiprant、ビラスチン、デスロラタジン、その他）、用途別販売分析（診療所、病院、その他）、地域別販売分析（米国、ヨーロッ...

世界のリポソーム薬物送達市場2019

Global Liposome Drug Delivery Sales Market Report 2019
QYR9N2277 2019年6月10日 113Pages
本調査レポートでは、リポソーム薬物送達の世界市場について調査・分析し、リポソーム薬物送達のメーカー別販売量、市場シェア分析、種類別販売分析（リポソームドキソルビシン、リポソームアムホテリシンB、リポソームパクリタキセル、その他）、用途別販売分析（がんと腫瘍治療、真菌感染症治療、その他）、地域別販売分...

世界の遺伝性疾患薬市場2019 The global Genetic Disorders Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Genetic Disorders Drug market status and forecast, categorizes the global Genetic Disorders Drug market size…
世界のスニチニブ薬市場：市場規模・現状・予測 Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on J…
世界のデュピュイトラン拘縮薬市場2019 The global Dupuytren Contracture Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Dupuytren Contracture Drug market status and forecast, categorizes the global Dupuytren Contracture Drug…
世界の下垂体ACTH過分泌薬市場2019 The global Pituitary ACTH Hypersecretion Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Pituitary ACTH Hypersecretion Drug market status and forecast, categorizes the global Pituitary …
世界の鼻ポリープ症薬市場2019 The global Nasal Polyposis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Nasal Polyposis Drug market status and forecast, categorizes the global Nasal Polyposis Drug market size (valu…